Improve Medical Instruments Co., Ltd. (300030.SZ)
CNY 6.6
(-2.37%)
CNY 6.6
(-2.37%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 79.9 Million | 42.47 Million | 171.73 Million | 141.27 Million | 49.16 Million | 56.03 Million |
| Net Income | -60.22 Million | -193.29 Million | 19.76 Million | 163.32 Million | 26.13 Million | -140.99 Million |
| Depreciation & Amortization | 45.12 Million | 46.75 Million | 53.31 Million | 37.48 Million | 35.63 Million | 38.18 Million |
| Deferred income taxes | 14.52 Million | -23.41 Million | 2.21 Million | -13.53 Million | 1.83 Million | -8.48 Million |
| Stock-based compensation | - | - | -4.82 Million | 6.51 Million | - | - |
| Change in working capital | 54.48 Million | -13.94 Million | 63.26 Million | -66.95 Million | -27.24 Million | -3.34 Million |
| Other non-cash items | 19.65 Million | 202.96 Million | 38 Million | 14.44 Million | 14.62 Million | 162.18 Million |
| Investing Cash Flow | -38.5 Million | -44.63 Million | -39.8 Million | -61.29 Million | -99.9 Million | -37 Million |
| Investments in PPE | -43.7 Million | -58.04 Million | -71.05 Million | -56.81 Million | -54.43 Million | -50.39 Million |
| Acquisitions | 3.6 Million | 26.59 Million | 125.21 Thousand | 56.9 Million | 3.72 Million | 4.1 Million |
| Investment purchases | -203.9 Million | -11.64 Million | -78.41 Million | -8 Million | -13.38 Million | -4.5 Million |
| Sales/Maturities of investments | 21.59 Million | 1.39 Million | 35.82 Million | 3.43 Million | 16.93 Million | 258.24 Thousand |
| Other Investing Activities | -20 Million | -2.94 Million | 73.7 Million | -56.81 Million | -52.74 Million | 13.52 Million |
| Financing Cash Flow | -50.09 Million | -120.82 Million | -2.56 Million | -58.31 Million | 11.37 Million | -52.79 Million |
| Debt repayment | -21.41 Million | -458.6 Million | -237.87 Million | -308.84 Million | -39 Million | -154.13 Million |
| Dividends payments | -15.93 Million | -12.36 Million | -9.88 Million | -26.79 Million | -26.13 Million | -30.65 Million |
| Common Stock Repurchased | - | - | - | -24.9 Million | - | - |
| Common Stock Issuance | - | - | - | 198.3 Thousand | -3.6 Million | 31.71 Million |
| Other Financing Activities | -12.73 Million | 375.44 Million | 266.45 Million | 302.02 Million | -1.5 Million | 131.98 Million |
| Accounts receivables | 52.76 Million | -12.59 Million | 109.82 Million | -77.44 Million | -370.31 Thousand | 60.65 Million |
| Accounts payables | 6.96 Million | 38.2 Million | -32.99 Million | 97.43 Million | -32.42 Million | -53.51 Million |
| Inventory | -19.77 Million | -16.14 Million | -15.77 Million | -73.4 Million | 3.72 Million | -1.99 Million |
| Other working capital | 21.49 Million | -23.41 Million | 2.21 Million | -13.53 Million | 1.83 Million | -1.34 Million |
| Cash at beginning of period | 219.47 Million | 341.48 Million | 212.99 Million | 193.71 Million | 233.28 Million | 268.16 Million |
| Cash at end of period | 211.39 Million | 219.47 Million | 341.48 Million | 212.99 Million | 193.71 Million | 233.28 Million |
| Capital Expenditure | -43.7 Million | -58.04 Million | -71.05 Million | -56.81 Million | -54.43 Million | -50.39 Million |
| Effect of forex changes on cash | 609.45 Thousand | 977.35 Thousand | -879.43 Thousand | -2.37 Million | -196.89 Thousand | -1.1 Million |
| Net cash flow / Change in cash | -8.08 Million | -122 Million | 128.48 Million | 19.28 Million | -39.57 Million | -34.88 Million |
| Free Cash Flow | 36.2 Million | -15.56 Million | 100.68 Million | 84.45 Million | -5.27 Million | 5.64 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -37.24 Million | -2.08 Million | -3.19 Million | -60.22 Million | -66.38 Million | -7.27 Million |
| Depreciation & Amortization | - | 10.51 Million | - | 45.12 Million | 12.51 Million | -22.56 Million |
| Deferred income taxes | - | - | - | 14.52 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 12.3 Million | - | 54.48 Million | 32.98 Million | -12.36 Million |
| Other non-cash items | 62.88 Million | 13.92 Million | 20.62 Million | 19.65 Million | 124.69 Million | 97.59 Million |
| Investing Cash Flow | -13.21 Million | -1.58 Million | 2.86 Million | -38.5 Million | -40.94 Million | -10.95 Million |
| Investments in PPE | -16.04 Million | -18.17 Million | -15.09 Million | -43.7 Million | -21.87 Million | -14 Million |
| Acquisitions | 9.99 Million | 10.01 Million | 16.53 Million | 3.6 Million | 596.52 Thousand | 3 Million |
| Investment purchases | - | - | - | -203.9 Million | -203.9 Million | -3 Million |
| Sales/Maturities of investments | 3.85 Million | 2.57 Million | 1.43 Million | 21.59 Million | 331.19 Thousand | 49.46 Thousand |
| Other Investing Activities | -1.03 Million | 4 Million | 17.96 Million | -20 Million | 85.5 Million | 3 Million |
| Financing Cash Flow | 38.39 Million | -68.97 Million | 6.65 Million | -50.09 Million | -26.22 Million | -7.02 Million |
| Debt repayment | -42.59 Million | -64.72 Million | -9.98 Million | -21.41 Million | -17.2 Million | -44.8 Million |
| Dividends payments | -2.54 Million | -4.39 Million | -2.74 Million | -15.93 Million | -2.09 Million | -2.17 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.66 Million | -4.25 Million | -588.75 Thousand | -12.73 Million | -6.92 Million | 39.95 Million |
| Accounts receivables | - | 37.58 Million | - | 52.76 Million | 52.76 Million | -7.77 Million |
| Accounts payables | - | - | - | 6.96 Million | - | -18.5 Million |
| Inventory | - | 2.92 Million | - | -19.77 Million | -19.77 Million | -4.58 Million |
| Other working capital | - | -28.2 Million | - | - | - | 18.5 Million |
| Cash at beginning of period | 168.55 Million | 240.57 Million | 211.39 Million | 219.47 Million | 232.91 Million | 195.36 Million |
| Cash at end of period | 219.22 Million | 169.16 Million | 237.28 Million | 211.39 Million | 211.39 Million | 232.91 Million |
| Capital Expenditure | -16.04 Million | -18.17 Million | -15.09 Million | -43.7 Million | -21.87 Million | -14 Million |
| Effect of forex changes on cash | -66.87 Thousand | 499.65 Thousand | 372.76 Thousand | 609.45 Thousand | 184.19 Thousand | 143.64 Thousand |
| Net cash flow / Change in cash | 50.66 Million | -71.41 Million | 25.89 Million | -8.08 Million | -21.52 Million | 37.55 Million |
| Free Cash Flow | 9.6 Million | -16.84 Million | 2.33 Million | 36.2 Million | 23.92 Million | 41.38 Million |
300171
CMCXF
300732
RGL
FAGI
AUROLAB